R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. R-flurbiprofen may be effective in delaying the recurrence of
localized prostate cancer.
PURPOSE: Randomized phase II trial to study the effectiveness of R-flurbiprofen in treating
patients who have localized prostate cancer at risk of recurrence following radiation therapy
and/or prostatectomy.